Microbot Medical Inc’s Market Journey: Closing Weak at 2.13, Down -2.74

Ulysses Smith

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

The closing price of Microbot Medical Inc (NASDAQ: MBOT) was $2.13 for the day, down -2.74% from the previous closing price of $2.19. In other words, the price has decreased by -$2.74 from its previous closing price. On the day, 2.94 million shares were traded. MBOT stock price reached its highest trading level at $2.2792 during the session, while it also had its lowest trading level at $2.105.

Ratios:

Our analysis of MBOT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.06 and its Current Ratio is at 12.06. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 13, 2020, Reiterated its Buy rating but revised its target price to $26 from $12 previously.

On December 24, 2019, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $10 to $12.

On January 31, 2018, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $1.75.Ladenburg Thalmann initiated its Buy rating on January 31, 2018, with a $1.75 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBOT now has a Market Capitalization of 143046656 and an Enterprise Value of 64487852.

Stock Price History:

The Beta on a monthly basis for MBOT is 1.20, which has changed by 1.2421052 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, MBOT has reached a high of $4.67, while it has fallen to a 52-week low of $0.89. The 50-Day Moving Average of the stock is -34.78%, while the 200-Day Moving Average is calculated to be -14.58%.

Shares Statistics:

MBOT traded an average of 4.28M shares per day over the past three months and 2628540 shares per day over the past ten days. A total of 67.16M shares are outstanding, with a floating share count of 66.94M. Insiders hold about 0.32% of the company’s shares, while institutions hold 9.51% stake in the company. Shares short for MBOT as of 1760486400 were 4225682 with a Short Ratio of 0.99, compared to 1757894400 on 10627521. Therefore, it implies a Short% of Shares Outstanding of 4225682 and a Short% of Float of 6.329999999999999.

Earnings Estimates

Currently, 1.0 analysts are dedicated to thoroughly evaluating and rating the performance of Microbot Medical Inc (MBOT) in the stock market.The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.

Analysts are recommending an EPS of between -$0.24 and -$0.24 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is $0.1, with 1.0 analysts recommending between $0.1 and $0.1.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $5M. There is a high estimate of $5M for the next quarter, whereas the lowest estimate is $5M.

Based on 1 analysts’ estimates, the company’s revenue will be $68M in the next fiscal year. The high estimate is $68M and the low estimate is $68M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.